Problems and solutions for primary stroke prevention, and polypill for stroke prevention. For the whole series of interviews, see #stroke#prevention#newapproach https://t.co/jcLtVlALAF
High CVD risk prevention strategies and failure to reduce stroke and CVD burden across the globe. Valery Feigin interview for VJNeurology
#stroke#prevention https://t.co/rcgH4ZOvDJ
National Institute for Stroke & Applied Neurosciences, Auckland University of Technology (New Zealand) research activities and output at glance https://t.co/TCkjBiEnqt
Tangible digital solutions for effective primary and secondary stroke/CVD and other major NCDs that share common risk factors with stroke/CVD are released by The Lancet Regional Health. Translations of the tools #in any languages i…https://t.co/QtFNHaDJBU https://t.co/ZM2HhioVNd
World Stroke Oorganization #digital#digital#webinar#webinar # # # # # webinar on digital technologies for primary and secondary stroke prevention https://t.co/TXKES3uWkc
National Institute of Stroke and Applied Neurosciences of Auckland University of Technology, New Zealand is one of the winners of the WHO Western Pacific Innovation Challenge (April 2022). https://t.co/odyZMHf44D
Do not miss the opportunity to register for the exiting international virtual meeting
The ICNE 2022 conference is due to start in just over a week, and we are really looking forward to e-meeting you there!
Please check out the website https://t.co/aYNy5gJ02l
Categorisation of people into low, moderate and high CVD risk is anachronism and should be abandoned, see joint WHF and WSO statement in Lancet https://t.co/E11k06uUJI